In-Person Return Visits Increased After Telemedicine Primary Care Visits
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
TUESDAY, Oct. 17, 2023 -- In-person return visits are slightly higher after primary care telemedicine versus in-person visits, according to a study published online Oct. 17 in the Annals of Internal Medicine.
Mary Reed, Dr.P.H., from the Kaiser Permanente Division of Research in Oakland, California, and colleagues compared treatment and follow-up visits between primary care video or telephone telemedicine and in-person office visits in a retrospective study based on administrative and electronic health record data between April and December 2021.
A total of 1,589,014 adult patients, with 2,357,598 primary care visits were included in the analyses. The researchers found that 50.8 percent of the primary care visits used telemedicine (19.5 and 31.3 percent video and telephone, respectively). Medications were prescribed in 46.8, 38.4, and 34.6 percent of office visits, video visits, and telephone visits, respectively, after adjustment. After the visit, 1.3, 6.2, and 7.6 percent of in-person visits, video visits, and telephone visits had a seven-day return in-person visit; 1.6, 1.8, and 2.1 percent, respectively, were followed by an emergency department visit. The largest differences in follow-up office visits after index office versus telephone visits were seen for acute pain conditions, and the smallest differences were seen for mental health.
"Overall, the rates of follow-up emergency department visit and hospitalizations were low, and differences between in-person visits and telemedicine visits were small," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.